{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T06:06:40Z","timestamp":1778134000905,"version":"3.51.4"},"reference-count":7,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["canadianjournalofophthalmology.ca","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Ophthalmology"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.jcjo.2017.01.009","type":"journal-article","created":{"date-parts":[[2017,3,15]],"date-time":"2017-03-15T01:31:11Z","timestamp":1489541471000},"page":"e152-e153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinically Occult Squamous Cell Carcinoma of Conjunctiva After Topical Immunotherapy for Ocular Surface Squamous Neoplasia"],"prefix":"10.1016","volume":"52","author":[{"given":"Frances A.","family":"Jacinto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Curtis E.","family":"Margo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcjo.2017.01.009_bib1","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0039-6257(05)80054-2","article-title":"Ocular surface squamous neoplasia","volume":"39","author":"Lee","year":"1995","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.jcjo.2017.01.009_bib2","first-page":"336","article-title":"Topical chemotherapy for ocular surface squamous neoplasia","volume":"24","author":"Nanji","year":"2013","journal-title":"Curr Opin"},{"key":"10.1016\/j.jcjo.2017.01.009_bib3","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1097\/ICO.0b013e3182a6ea6c","article-title":"Ocular surface squamous neoplasia: a survey of changes in the standard of care from 2003 to 2012","volume":"32","author":"Adler","year":"2013","journal-title":"Cornea"},{"key":"10.1016\/j.jcjo.2017.01.009_bib4","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.ophtha.2011.11.035","article-title":"Giant ocular surface squamous neoplasia managed with interferon alpha-2b as immunotherapy or immunoreduction","volume":"119","author":"Kim","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2017.01.009_bib5","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.ophtha.2013.11.017","article-title":"Surgical versus medical treatment of ocular surface squamous neoplasia. A comparison of recurrences and complications","volume":"12","author":"Nanji","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2017.01.009_bib6","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/eye.2014.62","article-title":"Ocular surface squamous neoplasia. Terminology that is conceptually friendly but clinically perilous","volume":"28","author":"Margo","year":"2014","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.jcjo.2017.01.009_bib7","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.ophtha.2011.08.028","article-title":"Ultra-high resolution optical coherence tomorgraphy for differentiation of ocular surface squamous neoplasia and pterygia","volume":"119","author":"Kieval","year":"2012","journal-title":"Ophthamology"}],"container-title":["Canadian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418216306007?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418216306007?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T20:05:09Z","timestamp":1757793909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008418216306007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":7,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0008418216306007"],"URL":"https:\/\/doi.org\/10.1016\/j.jcjo.2017.01.009","relation":{},"ISSN":["0008-4182"],"issn-type":[{"value":"0008-4182","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinically Occult Squamous Cell Carcinoma of Conjunctiva After Topical Immunotherapy for Ocular Surface Squamous Neoplasia","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcjo.2017.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Canadian Ophthalmological Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}